Elpen Pharmaceutical Co., Inc. (manufacturing, primary and secondary packaging, quality control, batch release of medicinal product)

Ukraine

All drugs from this manufacturer

  • IZIFRI

    The drug is used for maintenance bronchodilator therapy to relieve symptoms in chronic obstructive pulmonary disease (COPD).

    Dosage form: powder, inhalation, metered

    Active substance Dosage
    tiotropium bromide 10 mcg/dose

    ATC: R03BB04

  • The drug is indicated for the treatment of schizophrenia in adults and adolescents aged 13 years and older.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lurasidone 18.5 mg

    ATC: N05AE05

  • The drug is intended for the treatment of schizophrenia in adults and adolescents aged 13 years and older.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lurasidone 37 mg

    ATC: N05AE05

  • The drug is indicated for the treatment of schizophrenia in adults and adolescents aged 13 years and older.

    Dosage form: tablets, film-coated

    Active substance Dosage
    lurasidone 74 mg

    ATC: N05AE05